Answer
Anakinra neutralises interleukin-1 activity by competitively inhibiting its binding to the interleukin-1 type I receptor (IL-1RI).
Sources for this answer
- Kineret 100 mg solution for injection in a pre-filled syringeSwedish Orphan Biovitrum Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 20Document updated
Sources checked